What Is The Current and Historic Market Size Analysis Of The Biopharmaceutical Fermentation Systems Market?
The biopharmaceutical fermentation systems market has seen considerable growth due to a variety of factors.
• The biopharmaceutical fermentation systems market has seen substantial growth in recent years. It is expected to grow from $24.61 billion in 2024 to $26.86 billion in 2025, at a CAGR of 9.1%.
The growth is largely due to a higher demand for biologics, regulatory support, industry consolidation, increased investment in research and development, and a shifting healthcare landscape.
What are the Market Size and Expected Growth Rates for the Biopharmaceutical Fermentation Systems Market?
The biopharmaceutical fermentation systems market is expected to maintain its strong growth trajectory in upcoming years.
• The biopharmaceutical fermentation systems market is anticipated to grow significantly, reaching $38.39 billion by 2029, with a CAGR of 9.3%.
The growth is driven by the expansion of the biopharmaceutical pipeline, a shift toward personalized medicine, the adoption of continuous bioprocessing, the expansion of emerging markets, and advancements in automation and digitalization. Key trends include increased use of continuous manufacturing, growth in personalized medicine, biosimilars market expansion, adoption of advanced analytics and AI, and a focus on sustainability and environmental impact.
Which Key Drivers Are Propelling The Biopharmaceutical Fermentation Systems Market's Growth?
The growing biologics pipeline is expected to boost the biopharmaceutical fermentation systems market. Biologics are medical products derived from living organisms or their components, including vaccines and gene therapies. This market growth is driven by advancements in biotechnology and the increasing demand for targeted and personalized therapies. Biopharmaceutical fermentation systems support the production of biologics by cultivating genetically engineered cells to synthesize therapeutic proteins and vaccines. For instance, in 2023, the FDA approved 55 new drugs, including 25 new biological entities, representing a 50% increase from the previous year.
What Are The Key Segments Within The Global Biopharmaceutical Fermentation Systems Market?
The biopharmaceutical fermentation systems market covered in this report is segmented –
1) By Product: Upstream Products, Downstream Products
2) By Application: Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics, Other Applications
3) By End-User: Biopharmaceutical Companies, Contract Manufacturing Organizations, Contract Research Organizations, Academic Research Institutes, Food Industry, Other End-Users
Subsegments:
1) By Upstream Products: Fermenters Or Bioreactors, Culture Media, Inoculum Preparation Systems, Gas And Liquid Flow Control Systems, Process Monitoring And Control Systems, Sterilization Systems
2) By Downstream Products: Filtration Systems, Centrifuges, Chromatography Systems, Ultrafiltration And Microfiltration Systems, Concentration And Purification Systems, Packaging And Storage Systems
Pre-Book The Biopharmaceutical Fermentation Systems Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Emerging Market Trends Are Altering The Biopharmaceutical Fermentation Systems Industry?
In the biologics fermentation systems market, leading companies are advancing fermentation technologies, including automated bioreactors, to enhance production efficiency. Froilabo introduced fully automated lab-scale bioreactors in October 2022, designed to optimize growth conditions for microorganisms and cells. These bioreactors offer customizable features and precise control for various applications, providing valuable support for biopharmaceutical production and research.
Who Are the Key Players In The Biopharmaceutical Fermentation Systems Market?
Major companies operating in the biopharmaceutical fermentation systems market are:
• F. Hoffmann-La Roche Ltd.
• Thermo Fisher Scientific Inc.
• 3M Company
• Danaher Corporation
• Merck KGaA
• Becton Dickinson and Company
• GE Healthcare
• Agilent Technologies Inc.
• Lonza Group AG
• GEA Group AG
• Sartorius Stedim Biotech
• Bio-Rad Laboratories Inc.
• Pall Corporation
• Nova Biomedical
• Eppendorf AG
• Repligen Corporation
• ZETA Holding GmbH
• New Brunswick Scientific
• ABEC Inc.
• Pierre Guérin Technologies
• AntoXa Corporation
• Applikon Biotechnology
• Cellexus Ltd.
• Infors HT
• BioPharm Process Associates LLC
What Are The Regional Insights Into The Biopharmaceutical Fermentation Systems Market?
North America was the largest region in the biopharmaceutical fermentation systems market in 2023. The regions covered in the biopharmaceutical fermentation systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
